Why did US equities fall even after the FDA approved the emergency use of Pfizer’s vaccine? The Morning Run speaks to Stephen Innes, Chief Global Market Strategist at Axi, about the other factors affecting risk sentiment on Wall Street.



Stephen also gets into the current US IPO mania with thoughts on Doordash and Airbnb, the value proposition of AstraZeneca's $39 billion takeover of Alexion, as well as how he's positioning his portfolio going into 2021.

Why did US equities fall even after the FDA approved the emergency use of Pfizer&rsquo;s vaccine? The Morning Run speaks to Stephen Innes, Chief Global Market Strategist at Axi, about the other factors affecting risk sentiment on Wall Street.

Stephen also gets into the current US IPO mania with thoughts on Doordash and Airbnb, the value proposition of AstraZeneca's $39 billion takeover of Alexion, as well as how he's positioning his portfolio going into 2021.

Dovish or hawkish? Over or underweight? Bull or Bear? Investor paralysis? We speak to leading local and foreign analyst to find out how the different asset classes and markets will react to the latest news, results and even geopolitical events.

Dovish or hawkish? Over or underweight? Bull or Bear? Investor paralysis? We speak to leading local and foreign analyst to find out how the different asset classes and markets will react to the latest news, results and even geopolitical events.

Advertisement